(IN BRIEF) In early 2024, Europe's medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like…
(IN BRIEF) A study led by researchers at the University of Helsinki highlights the need for a more comprehensive approach…
(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class…
SOUTHAMPTON, 02-Apr-2018 — /EuropaWire/ — Many patients receiving chemotherapy following surgery for bowel cancer may only need three months treatment rather…
World’s first complete Sample to Insight NGS solution proves equal or better compared with other sequencing workflows and alternative technologies…
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of…